Joining EMBL as technology developer and engineer
Integrated structure and metabolomics platform for microbial targets
ARISE fellowship position, deadline: September 30, 2023
The Wilmanns Group at the EMBL Hamburg Unit aims to establish a multidisciplinary metabolomics/structure service platform for determination of turnover mechanisms of specific drugs or prodrugs by different microorganisms, in collaboration with Michael Zimmermann, Structural & Computational Biology Unit, EMBL Heidelberg. The platform will include establishment of a pipeline for high resolution structures of selected protein-drug complexes in microorganisms, and in-vitro analysis of the enzymatic processing of specific drugs by microorganisms.
In case of further interest please contact:
Matthias Wilmanns, email: matthias.wilmanns@embl-hamburg.de
Michael Zimmermann, email: michael.zimmermann@embl.de
Further information can be found on website, including eligibility criteria
